Breaking News

CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says

CanSino Biologics Inc's (CanSinoBIO) COVID-19 vaccine showed 65.7% efficacy in preventing symptomatic cases and a 90.98% success rate in stopping severe disease in an interim analysis of global trials, Pakistan's health minister said on Monday.

from bdnews24.com - Home https://ift.tt/3aPr67h

No comments